Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes
Diabetes · 2024
DOI: 10.2337/db24-0083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Max C Petersen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Muscle, Skeletal, Obesity, Weight Loss. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Washington University Nutrition and Obesity Research Center, NCATS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Muscle sn-1,2-diacylglycerol (DAG) and C18:0 ceramide accumulation in sarcolemmal and mitochondrial compartments have been proposed to regulate muscle insulin sensitivity. Here, we evaluated whether weight loss-induced improvements in insulin sensitivity were associated with changes in muscle sn-1,2-DAG and ceramide content in people with obesity and type 2 diabetes. We measured skeletal muscle insulin sensitivity, assessed by using the hyperinsulinemic-euglycemic clamp procedure in conjunction with stable isotopically labeled glucose tracer infusion, and skeletal muscle sn-1,2-DAG and ceramide contents by using liquid chromatography–tandem mass spectrometry after subcellular fractionation and DAG isomer separation in 14 adults with obesity and type 2 diabetes before and after marked (18.6 ± 2.1%) weight loss. Whole-body insulin sensitivity doubled after weight loss. Sarcolemmal sn-1,2-DAG and C18:0 ceramide contents after weight loss were not different from values before weight loss. In contrast, mitochondrial-endoplasmic reticulum (ER) C18:0 ceramide content decreased by ∼20% after weight loss (from 2.16 ± 0.08 to 1.71 ± 0.13 nmol/g, P < 0.005). These results suggest a decrease in muscle mitochondrial-ER C18:0 ceramide content could contribute to the beneficial effect of weight loss on skeletal muscle insulin sensitivity. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO.
- Division of Endocrinology, Metabolism, & Lipid Research, Washington University in St. Louis, St. Louis, MO.
- Departments of Internal Medicine and Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT.
ORCID-Profile: Max C Petersen, Dmitri Samovski, Samuel Klein
Förderung
- NIDDK NIH HHS
- Washington University Nutrition and Obesity Research Center
- NCATS NIH HHS
- Washington University Institute of Clinical and Translational Sciences
- ICTS Institutional Career Development Program
- Washington University Diabetes Research Center
- NIH HHS
- Yale Diabetes Research Center
Zitieren
APA
Petersen, M. C., Yoshino, M., Smith, G. I., Gaspar, R. C., Kahn, M., Samovski, D., Shulman, G. I., & Klein, S. (2024). Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes. Diabetes. https://doi.org/10.2337/db24-0083
Vancouver
Petersen MC, Yoshino M, Smith GI, Gaspar RC, Kahn M, Samovski D, et al. Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes. Diabetes. 2024. doi:10.2337/db24-0083
BibTeX
@article{Petersen2024,
author = {Petersen, Max C and Yoshino, Mihoko and Smith, Gordon I and Gaspar, Rafael C and Kahn, Mario and Samovski, Dmitri and Shulman, Gerald I and Klein, Samuel},
title = {Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db24-0083}
}
EUVIMED